ClinicalTrials.gg
RecruitingNCT07899385Updated Oct 30, 2026

Effects of Scapular Training on Adolescent Boxers

An interventional study of Scapular Stabilization Exercise Program and Standard Physiotherapy Exercise Program in Sports Physical Therapy, sponsored by Istinye University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 10 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Istinye University · Not applicable, Interventional, and Treatment

Updated Oct 30, 2026Interventions changedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
10 Years to 19 Years
Sex
All
01

Study summary

Boxing is a combat sport that requires repetitive, high-speed upper extremity movements, placing substantial demands on shoulder stability, scapular control, and neuromuscular coordination. Repetitive punching movements may contribute to scapular dyskinesis, shoulder dysfunction, and impaired upper extremity performance. Scapular stabilization exercises aim to improve scapular positioning, muscle activation, and movement coordination by targeting key stabilizing muscles, including the serratus anterior and trapezius.

The aim of this study is to investigate the effects of scapular stabilization exercises on scapular control and upper extremity performance in adolescent boxers. Scapular control, muscular endurance, stability, strength, balance, and reaction time will be assessed to determine changes following the exercise intervention. The findings are expected to provide evidence regarding the potential benefits of scapular stabilization training for improving upper extremity function and sports performance in adolescent boxers.

02

Conditions studied

  • Sports Physical Therapy

Keywords

  • Adolescent boxers
  • scapular control
  • Upper Extremity Performance
03

In context

Lead sponsor

Istinye University is the lead sponsor of 221 studies on the registry; 94 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Must be a licensed athlete
  2. Must have been boxing for at least 2-3 years
  3. Must be between the ages of 10 and 19
  4. Must not have previously undergone any exercise-based treatment for the scapula
  5. Maximum pain score of 5/10 or less on the Numerical Rating Scale (NRS)
  6. Ability to continue the program
  7. Voluntary participation in the study

Exclusion criteria

Exclusion Criteria:

  1. Presence of concomitant mental health issues, rheumatological, neuromuscular, cardiovascular, or pulmonary conditions
  2. Rotator cuff tendon tears across all layers, fractures, dislocations, nerve injuries, and other conditions causing shoulder pain.
  3. History of trauma or shoulder surgery.
  4. Patients with scoliosis or acute cervical spondylosis.
  5. Shoulder flexion or abduction angle less than 90°.
  6. History of a serious musculoskeletal injury or surgery within the past 6 months
  7. Presence of vision and/or hearing loss
  8. Communication difficulties
  9. Active infections, active inflammatory diseases, tumors, neurological disorders, and changes in cognitive function (such as stroke, epilepsy, Parkinson's disease, and peripheral neuropathy), systemic diseases affecting the joints (such as rheumatoid arthritis), and severe osteoporosis-as well as other conditions that are incompatible with or prevent completion of the treatment plan.
  10. Patients who refuse to undergo treatment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
52 participants (estimated)

Study arms

  • Active comparator
    Conventional Physiotherapy Group

    Participants in the control group will receive education on scapular dyskinesis, including its causes, underlying mechanisms, postural recommendations, and the benefits of exercise. They will be instructed to perform a standard physiotherapy exercise program consisting of 30-minute sessions, three times per week for six weeks (18 sessions in total).

    Other: Standard Physiotherapy Exercise Program

  • Experimental
    Scapular Stabilization Exercise Group

    Participants in the experimental group will receive education on scapular dyskinesis, including its definition, causes, underlying mechanisms, postural considerations, and the benefits of exercise. They will participate in a progressive scapular stabilization exercise program consisting of 30-minute sessions, three times per week for six weeks (18 sessions in total). Exercise progression will be individualized according to each athlete's condition and performance. Participants will be verbally questioned about potential exercise-related adverse effects before and after each session.

    Other: Scapular Stabilization Exercise Program

Interventions

  • OtherScapular Stabilization Exercise Program

    A structured, progressive scapular stabilization exercise program designed to improve scapular control, neuromuscular coordination, muscular endurance, and upper extremity stability and performance. The program will be administered for 30 minutes per session, three times weekly for six weeks, totaling 18 sessions.

  • OtherStandard Physiotherapy Exercise Program

    A standard physiotherapy exercise program combined with patient education. Participants will be instructed to perform the exercises for 30 minutes per session, three times weekly for six weeks, totaling 18 sessions.

06

What researchers measure

Primary outcomes

  1. Scapular Dyskinesis

    Scapular dyskinesis will be assessed using the Scapular Dyskinesis Test (SDT). Participants will perform five repetitions of bilateral shoulder flexion and abduction while holding weights of 1.4 kg or 2.3 kg, depending on body weight. Scapular movements will be visually observed and classified as dyskinesis present or absent based on abnormal scapular motion or asymmetry.

    Time frame: 6 weeks

  2. Lateral Scapular Slide Test

    Scapular position and symmetry will be assessed using the Lateral Scapular Slide Test (LSST). The distance between the inferior angle of the scapula and the thoracic spinous processes will be measured bilaterally in three arm positions: 0°, 45°, and 90° of shoulder abduction. Side-to-side differences will be recorded in centimeters (cm). A difference greater than 1.5 cm will be considered indicative of scapular asymmetry.

    Time frame: 6 weeks

Secondary outcomes

  1. Medicine Ball Throw Test

    Upper extremity explosive power will be evaluated using the Medicine Ball Throw Test. Participants will throw a standardized medicine ball forward with maximal effort from a standardized seated or kneeling position. Throwing distance will be recorded in meters (m), with greater distances indicating better explosive upper extremity performance.

    Time frame: 6 weeks

  2. Upper Quarter Y Balance Test

    Upper extremity dynamic balance and stability will be assessed using the Upper Quarter Y Balance Test (UQYBT). Participants will maintain a weight-bearing position on one upper extremity while reaching with the opposite hand in the medial, inferolateral, and superolateral directions. Maximum reach distances will be recorded in centimeters (cm), and a composite score will be calculated. Greater reach distances and composite scores indicate better dynamic stability.

    Time frame: 6 weeks

  3. Closed Kinetic Chain Upper Extremity Stability Test

    Functional upper extremity stability will be evaluated using the Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST). Participants will assume a push-up position with their hands positioned 91.4 cm apart and alternately touch the opposite hand for 15 seconds. The total number of touches completed within 15 seconds will be recorded. Higher scores indicate better upper extremity functional stability and performance.

    Time frame: 6 weeks

  4. 30-Second Repeated Punch Test

    Boxing-specific upper extremity performance will be assessed using the 30-Second Repeated Punch Test. Participants will perform the maximum possible number of straight punches against a standardized punching bag over 30 seconds. The total number of punches will be recorded, with higher values indicating better boxing-specific repetitive punching performance.

    Time frame: 6 weeks

  5. Punch Fatigue Index

    Punching fatigue will be evaluated using three 30-second bouts of maximal straight punches against a punching bag, separated by 30-second rest intervals. The number of punches performed in each bout will be recorded. The Punch Fatigue Index will be calculated as \[(maximum punch count - minimum punch count) / maximum punch count\] × 100. Scores will be expressed as percentages (%), with lower values indicating better maintenance of punching performance across repeated bouts.

    Time frame: 6 weeks

  6. Handgrip Strength

    Handgrip strength will be measured using a hand dynamometer. Participants will be seated with the shoulder adducted, elbow flexed at 90°, and forearm in a neutral position. Three maximal voluntary contractions will be performed, and the highest value will be recorded as the handgrip strength measurement.

    Time frame: 6 weeks

  7. Muscle Strength

    Isometric shoulder abduction, external rotation, serratus anterior and lower trapezius strength will be assessed using a handheld dynamometer. Participants will perform maximal voluntary isometric contractions in standardized testing positions. Muscle strength will be recorded separately for shoulder abduction and external rotation, with higher values indicating greater muscle strength.

    Time frame: 6 weeks

  8. Reaction Time

    Visual reaction time will be assessed using the BlazePod system. Participants will respond as quickly as possible to randomly activated visual stimuli by touching the illuminated pods. Response times will be recorded in milliseconds (ms), with shorter reaction times indicating better neuromotor response performance.

    Time frame: 6 weeks

  9. Athlete-Perceived Performance Satisfaction

    Athlete-perceived performance satisfaction will be evaluated using an 11-point Numeric Rating Scale (NRS). Participants will rate their satisfaction with their performance during training on a scale from 0 (not satisfied at all) to 10 (completely satisfied). Higher scores indicate greater perceived performance satisfaction.

    Time frame: 6 weeks

  10. Global Rating of Change (GROC)

    Participants' perceived overall change following the intervention will be assessed using the Global Rating of Change (GROC) scale. Participants will rate their perceived change compared with their condition before the intervention on a 7-point scale ranging from -3 (much worse) to +3 (much better), with 0 indicating no change. Higher positive scores indicate greater perceived improvement.

    Time frame: 6 weeks

07

Study locations

1 of 1 sites recruiting
08

Updates

2 registry updates since Sep 25, 2026
Interventions
Arm changed Control group→Conventional Physiotherapy Group; İntervention group→Scapular Stabilization Exercise Group
Oct 30, 2026
Registered
First appeared on the registry
Oct 27, 2026
Show all 2 updates
  1. Oct 30, 2026
    Interventions Arm changed Control group→Conventional Physiotherapy Group; İntervention group→Scapular Stabilization Exercise Group
    + 2 other changes: responsible party and conditions
  2. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07899385
Lead sponsor
Istinye University
Responsible party
Hale Nur Aykaç (Principal Investigator, Istinye University) — Principal investigator
First posted
Oct 27, 2026
Start date
Oct 25, 2026 (estimated)
Primary completion
Feb 28, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Oct 30, 2026

Study contacts

Kubra Kardes, Asst. Prof.
Contact
kubrakoce@gmail.com
05387115631

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion